Latham & Watkins advised Exscientia on the deal, while Goodwin Procter LLP advised Novo Holdings. Exscientia, the world leading artificial intelligence (AI) drug company, raised $60…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now